30
Participants
Start Date
May 31, 2002
Primary Completion Date
September 30, 2008
Study Completion Date
March 31, 2009
multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)
multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides at days 1, 30,90,180
T cell vaccination
Multiple injections of autologous T cell lines reactive to 9 myelin peptides.
Dept of Neurology,Hadassah ein-Kerem, Jerusalem
Hadassah Medical Organization
OTHER